Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_3
7
54%
Ph phase_4
3
23%

Phase Distribution

1

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
7(63.6%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(13)

Detailed Status

Completed13

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 37 (63.6%)
Phase 43 (27.3%)

Trials by Status

completed13100%

Recent Activity

0 active trials
Showing 5 of 13
completed

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

NCT01690533
completedphase_4

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

NCT00668304
completedphase_3

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

NCT00769171
completedphase_3

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

NCT00431678
completedphase_3

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

NCT00828971
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT01690533

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

Completed
NCT00668304Phase 4

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

Completed
NCT00769171Phase 3

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

Completed
NCT00431678Phase 3

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

Completed
NCT00828971Phase 3

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

Completed
NCT00656747Phase 4

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

Completed
NCT00665327Phase 4

Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

Completed
NCT00717561Phase 3

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Completed
NCT00473460Phase 3

Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

Completed
NCT00683865Phase 3

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

Completed
NCT01014247Phase 1

Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

Completed
NCT00930488

Treatment of Patients With Acute Sinusitis

Completed
NCT01045902Phase 3

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13